Carmenta Bioscience Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 4
Employees
  • Latest Deal Type
  • M&A

Carmenta Bioscience General Information

Description

Developer of serum based diagnostic test for preeclampsia. The company focuses on maternal and fetal health by applying a systems biology approach to the diagnosis and prediction of preeclampsia.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 4240 Wilkie Way
  • Palo Alto, CA 94306
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Carmenta Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 29-Apr-2015 000 Completed Startup
2. Accelerator/Incubator 26-Aug-2013 000 Completed Product Development
1. Seed Round 07-Aug-2013 $2M $2M Completed Product Development
To view Carmenta Bioscience’s complete valuation and funding history, request access »

Carmenta Bioscience Board Members (3)

Name Representing Role Since
Atul Butte MD Self Co-Founder & Co-Chair, Scientific Advisory Board 000 0000
Bruce Ling Self Co-Founder & Co-Chair, Scientific Advisory Board 000 0000
Camille Samuels Self Board Member 000 0000
To view Carmenta Bioscience’s complete board members history, request access »

Carmenta Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carmenta Bioscience Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
Life Science Angels Angel Group Minority 000 0000 000000 0
StartX (US) Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Carmenta Bioscience’s complete investors history, request access »